Literature DB >> 3591369

Effects of neuropeptide Y (NPY) on isolated guinea-pig heart.

C Wahlestedt, B Wohlfart, R Håkanson.   

Abstract

Neuropeptide Y (NPY) is present in nerve fibres throughout the mammalian heart. We have elucidated the effects of NPY on the isolated papillary muscle and heart (Langendorff) from the guinea-pig. The paced papillary muscle was studied with regard to duration of the action potential, peak force, maximum rate of force development, time to peak force, and time from peak force to half relaxation; all these parameters were identical whether or not NPY (5 X 10(-7) M) was present in the medium. When a stimulation with trains of pulses was superimposed, the paced papillary muscle exhibited enhanced contractions. This increase in contractility was not observed in the presence of the beta-adrenoceptor antagonist propranolol (10(-6) M) and was thus considered to be adrenergically mediated. The latter (adrenergic) response was markedly attenuated by NPY. Since NPY did not interfere with the response to exogenous noradrenaline (NA) it is suggested that the peptide exerts a pre-junctional inhibitory affect on adrenergic nerve-mediated positive inotropy. Neuropeptide Y did not influence the electrocardiogram from the spontaneously beating heart (Lagendorff), nor did the peptide modify the positive chronotropic effect of exogenously applied NA. In conclusion, the results indicate that NPY is without effect on the heart muscle proper but that the sympathetic terminals of the heart possess pre-junctional receptors for NPY (and/or related peptides) related to suppression of stimulated NA release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591369     DOI: 10.1111/j.1365-201x.1987.tb10618.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  7 in total

Review 1.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.

Authors:  H M Piper; B C Millar; B J McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

4.  Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.

Authors:  Q P Feng; T Hedner; B Andersson; J M Lundberg; F Waagstein
Journal:  Br Heart J       Date:  1994-03

5.  Transmural regulation of myocardial perfusion by neuropeptide Y.

Authors:  D D Gutterman; D A Morgan
Journal:  Basic Res Cardiol       Date:  1995 Jul-Aug       Impact factor: 17.165

6.  The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte.

Authors:  B C Millar; H M Piper; B J McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

7.  The effects of neuropeptide Y on myocardial contractility and coronary blood flow.

Authors:  S J Awad; R Einstein; E K Potter; D P Richardson
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.